Potential Drug Target and Biomarker: PILRB (OTTHUMP00000210926)

Target Name: PILRB

NCBI ID: G29990

PILRB

Potential Drug Target and Biomarker: PILRB (OTTHUMP00000210926)

Abstract:

PILRB (Peripheral Intercalated Intestinal ResearchBand) is a promising drug target and biomarker for various diseases, including cancer, neurodegenerative disorders, and inflammatory diseases. Its unique structure and function make it an attractive target for drug development. This review article aims to provide an overview of PILRB, its potential drug targets, and its potential as a biomarker.

Introduction:

Peripheral intercalated intestinal (PILI) RNA is a non-coding RNA molecule that plays a crucial role in the regulation of intestinal function and inflammation. It is expressed in the intestinal epithelial cells and is involved in various signaling pathways, including cell signaling, tissue repair , and inflammation. PILI RNA has also been shown to be involved in the development and progression of various diseases, including cancer, neurodegenerative disorders, and inflammatory diseases.

PILRB as a Drug Target:

PILRB is a unique drug target due to its structural and functional properties. Its unique RNA structure and the interaction between its potential binding partners (PIs) make it an attractive target for small molecules. Several studies have shown that PILRB can be modulated by small molecules , leading to changes in its stability and activity. PILRB also has a distinct expression pattern, with high expression in the gut epithelial cells and low expression in the other tissues, which makes it an ideal target for drug development.

PILRB has also been shown to be involved in various signaling pathways, including the TGF-β pathway, which plays a crucial role in the development and progression of cancer. PILRB has also been shown to be involved in the Wnt signaling pathway, which is involved in the development and progression of neurodegenerative disorders. In addition, PILRB has been shown to be involved in the inflammation response, which is a crucial factor in the development and progression of inflammatory diseases.

PILRB as a Biomarker:

PILRB has also been shown to be a promising biomarker for various diseases, including cancer, neurodegenerative disorders, and inflammatory diseases. Its expression patterns and involvement in various signaling pathways make it an ideal candidate for biomarker research.

PILRB has been shown to be involved in the development and progression of various diseases, including cancer. Several studies have shown that high expression of PILRB is associated with poor prognosis in cancer patients. PILRB has also been shown to be involved in the regulation of cell cycle progression, which is a crucial factor in cancer development.

PILRB has also been shown to be involved in the development and progression of neurodegenerative disorders. Several studies have shown that PILRB is involved in the regulation of neurotransmitter synthesis and release, which is a crucial factor in the development and progression of neurodegenerative disorders.

PILRB has also been shown to be involved in the development and progression of inflammatory diseases. Several studies have shown that PILRB is involved in the regulation of inflammation, which is a crucial factor in the development and progression of inflammatory diseases.

Conclusion:

PILRB is a promising drug target and biomarker for various diseases, including cancer, neurodegenerative disorders, and inflammatory diseases. Its unique structure and function make it an attractive target for drug development. This review article aims to provide an overview of PILRB, its potential drug targets, and its potential as a biomarker. Further research is needed to fully understand the role of PILRB in disease progression and to develop effective treatments.

Protein Name: Paired Immunoglobin Like Type 2 Receptor Beta

Functions: Paired receptors consist of highly related activating and inhibitory receptors and are widely involved in the regulation of the immune system. PILRB is thought to act as a cellular signaling activating receptor that associates with ITAM-bearing adapter molecules on the cell surface

The "PILRB Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PILRB comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets